应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LIAN 联拓生物
退市 11-04 16:00:00 EST
0.3190
+0.0000
0.00%
最高
0.3190
最低
0.3190
成交量
0.00
今开
0.3190
昨收
0.3190
日振幅
0.00%
总市值
3,450万
流通市值
810.52万
总股本
1.08亿
成交额
0.00
换手率
0.00%
流通股本
2,541万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
【丽珠医药(01513.HK)及Kalbe拟通过附属公司以现金方式出资在印度尼西亚设立合资公司】智通财经APP讯,丽珠医药(01513.
智通财经 · 07-29
【丽珠医药(01513.HK)及Kalbe拟通过附属公司以现金方式出资在印度尼西亚设立合资公司】智通财经APP讯,丽珠医药(01513.
【丽珠集团(000513.SZ)拟与Kalbe通过附属公司在印度尼西亚设立合资公司】智通财经APP讯,丽珠集团(000513.
智通财经 · 07-29
【丽珠集团(000513.SZ)拟与Kalbe通过附属公司在印度尼西亚设立合资公司】智通财经APP讯,丽珠集团(000513.
【丽珠集团:拟投资2612亿印尼盾设立合资公司】金十数据7月29日讯,丽珠集团公告,公司全资附属公司LIAN SGP与Kalbe控股附属公司PT GCM签署《股东协议》,双方以现金方式出资在印度尼西亚设立合资公司。
美港电讯 · 07-29
【丽珠集团:拟投资2612亿印尼盾设立合资公司】金十数据7月29日讯,丽珠集团公告,公司全资附属公司LIAN SGP与Kalbe控股附属公司PT GCM签署《股东协议》,双方以现金方式出资在印度尼西亚设立合资公司。
睿智医药:控股股东与董事长涉2亿元诉讼睿智医药公告,公司控股股东北海八本近日收到《广东省江门市中级法院民事诉前调解通知书》,公司董事长WOO SWEE LIAN(胡瑞连)为原告,北海八本为被告,涉案金额2亿元。
格隆汇 · 07-26
睿智医药:控股股东与董事长涉2亿元诉讼睿智医药公告,公司控股股东北海八本近日收到《广东省江门市中级法院民事诉前调解通知书》,公司董事长WOO SWEE LIAN(胡瑞连)为原告,北海八本为被告,涉案金额2亿元。
【远大医药(00512.HK)引进全球创新的治疗蠕形螨睑缘炎及蠕形螨导致的睑板腺功能障碍产品】智通财经APP讯,远大医药(00512.
智通财经 · 03-27
【远大医药(00512.HK)引进全球创新的治疗蠕形螨睑缘炎及蠕形螨导致的睑板腺功能障碍产品】智通财经APP讯,远大医药(00512.
联拓生物盘中异动 股价大跌8.02%
自选股智能写手 · 03-18
联拓生物盘中异动 股价大跌8.02%
联拓生物股价上涨13.00% 市值涨419.56万美元
自选股智能写手 · 03-15
联拓生物股价上涨13.00% 市值涨419.56万美元
联拓生物决定自愿从美国纳斯达克退市以减轻运营负担
金融界 · 02-29
联拓生物决定自愿从美国纳斯达克退市以减轻运营负担
联拓生物(LIAN.US)自愿从纳斯达克退市 预计将在OTC市场交易
智通财经 · 02-28
联拓生物(LIAN.US)自愿从纳斯达克退市 预计将在OTC市场交易
加载更多
公司概况
公司名称:
联拓生物
所属市场:
NASDAQ
上市日期:
--
主营业务:
LianBio于2019年7月17日在开曼群岛注册成立。该公司是一家全球性的、以科学为导向的生物制药公司,致力于为未满足医疗需求的患者开发和商业化创新药物,最初专注于大中华区和其他亚洲市场的授权资产。该公司有目的地设计了他们的组织,通过识别、采购、开发和商业化候选产品以及与世界各地高度创新的生物制药公司合作,成功地执行他们的愿景。该公司正在建立一个国际基础设施,将他们自己定位为首选合作伙伴,并提供一个平台,以提供进入其目标市场的机会。
发行价格:
--
{"stockData":{"symbol":"LIAN","market":"US","secType":"STK","nameCN":"联拓生物","latestPrice":0.319,"timestamp":1730754000000,"preClose":0.319,"halted":4,"volume":0,"delay":0,"floatShares":25408205,"shares":108165130,"eps":-0.819144,"marketStatus":"退市","marketStatusCode":0,"change":0,"latestTime":"11-04 16:00:00 EST","open":0.319,"high":0.319,"low":0.319,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.819144,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1730797200000},"adr":0,"listingDate":1635739200000,"adjPreClose":0.319,"adrRate":1,"volumeRatio":0},"requestUrl":"/m/hq/s/LIAN","defaultTab":"news","newsList":[{"id":"2455651416","title":"【丽珠医药(01513.HK)及Kalbe拟通过附属公司以现金方式出资在印度尼西亚设立合资公司】智通财经APP讯,丽珠医药(01513.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455651416","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455651416?lang=zh_cn&edition=full","pubTime":"2024-07-29 20:02","pubTimestamp":1722254524,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PT","BK1191","01513","LIAN","BK4139","BK4166"],"gpt_icon":0},{"id":"2455658498","title":"【丽珠集团(000513.SZ)拟与Kalbe通过附属公司在印度尼西亚设立合资公司】智通财经APP讯,丽珠集团(000513.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455658498","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455658498?lang=zh_cn&edition=full","pubTime":"2024-07-29 18:45","pubTimestamp":1722249911,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0188","BK4166","BK0187","BK0028","PT","000513","LIAN","BK0239","BK4139"],"gpt_icon":0},{"id":"2455863090","title":"【丽珠集团:拟投资2612亿印尼盾设立合资公司】金十数据7月29日讯,丽珠集团公告,公司全资附属公司LIAN SGP与Kalbe控股附属公司PT GCM签署《股东协议》,双方以现金方式出资在印度尼西亚设立合资公司。","url":"https://stock-news.laohu8.com/highlight/detail?id=2455863090","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455863090?lang=zh_cn&edition=full","pubTime":"2024-07-29 18:33","pubTimestamp":1722249210,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0188","BK0187","BK4166","LIAN","BK4139","PT","BK0239","BK0028","000513"],"gpt_icon":0},{"id":"2454415373","title":"睿智医药:控股股东与董事长涉2亿元诉讼睿智医药公告,公司控股股东北海八本近日收到《广东省江门市中级法院民事诉前调解通知书》,公司董事长WOO SWEE LIAN(胡瑞连)为原告,北海八本为被告,涉案金额2亿元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2454415373","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454415373?lang=zh_cn&edition=full","pubTime":"2024-07-26 20:42","pubTimestamp":1721997776,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4139","BK0077","LIAN","300149","BK0216"],"gpt_icon":0},{"id":"2422504329","title":"【远大医药(00512.HK)引进全球创新的治疗蠕形螨睑缘炎及蠕形螨导致的睑板腺功能障碍产品】智通财经APP讯,远大医药(00512.","url":"https://stock-news.laohu8.com/highlight/detail?id=2422504329","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422504329?lang=zh_cn&edition=full","pubTime":"2024-03-27 17:30","pubTimestamp":1711531853,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["00512","TARS","LIAN","BK4139","BK4007","BK1191"],"gpt_icon":0},{"id":"2420474592","title":"联拓生物盘中异动 股价大跌8.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420474592","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2420474592?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:32","pubTimestamp":1710768720,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时32分,联拓生物股票出现异动,股价快速跳水8.02%。截至发稿,该股报0.320美元/股,成交量27.2625万股,换手率0.25%,振幅4.00%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予持有建议,无券商给予买入、卖出建议。联拓生物股票所在的生物技术行业中,整体涨幅为0.10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182132008b434d4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182132008b434d4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIAN"],"gpt_icon":0},{"id":"2419974561","title":"联拓生物股价上涨13.00% 市值涨419.56万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419974561","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2419974561?lang=zh_cn&edition=full","pubTime":"2024-03-15 21:30","pubTimestamp":1710509446,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日21时30分,联拓生物股票出现异动,股价快速上涨13.00%。截至发稿,该股报0.271美元/股,成交量771.107万股,换手率7.14%,振幅1.17%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予持有建议,无券商给予买入、卖出建议。联拓生物股票所在的生物技术行业中,整体涨幅为0.11%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315213046861dea93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315213046861dea93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIAN","BK4139"],"gpt_icon":0},{"id":"2415034003","title":"联拓生物决定自愿从美国纳斯达克退市以减轻运营负担","url":"https://stock-news.laohu8.com/highlight/detail?id=2415034003","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2415034003?lang=zh_cn&edition=full","pubTime":"2024-02-29 01:36","pubTimestamp":1709141785,"startTime":"0","endTime":"0","summary":"联拓生物计将于2024年3月11日左右向美国证券交易委员会和纳斯达克提交关于其美国存托凭证自愿退市的表格。这一决定意味着,在退市之后,联拓生物的ADS将不再在纳斯达克公开交易,而只能通过私下协商的方式进行交易,可能会转至场外交易市场。联拓生物此前已透露,在董事会完成对公司的全面战略评估后,公司已开始逐步关闭其业务,包括公司普通股和美国存托凭证的自愿退市和注销。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022901404287cd82b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022901404287cd82b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QQQ","SQQQ","BK4007","TQQQ","NQmain","BK4139","ARTL","QLD","LIAN","PSQ","MNQmain","NDX",".IXIC","QID"],"gpt_icon":0},{"id":"2414323543","title":"联拓生物(LIAN.US)自愿从纳斯达克退市 预计将在OTC市场交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2414323543","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2414323543?lang=zh_cn&edition=full","pubTime":"2024-02-28 20:38","pubTimestamp":1709123933,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,联拓生物(LIAN.US)2月28日宣布,已向纳斯达克交易所发出通知,其打算将公司的美股ADS从纳斯达克全球市场(Nasdaq Global Market)摘牌。联拓生物在一份声明中表示,预计将于2024年3月11日前后向美国证券交易委员会(SEC)和纳斯达克提交一份有关其ADS自愿退市的Form 25。该公司预计其ADS将在OTC Markets Group运营的市场上进行报价,以便其ADS的交易市场可以继续存在。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1078544.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NQmain",".IXIC","BK4007","QQQ","LIAN","QLD","BK4139","TQQQ","ARTL","NDX","03086","SQQQ","QID","PSQ","BK1147","MNQmain"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lianbio.com;www.lianbiopharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":-0.9237},{"period":"ytd","weight":-0.9286}],"compareEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0716},{"period":"6month","weight":0.1169},{"period":"1year","weight":0.3257},{"period":"ytd","weight":0.2014}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"LianBio于2019年7月17日在开曼群岛注册成立。该公司是一家全球性的、以科学为导向的生物制药公司,致力于为未满足医疗需求的患者开发和商业化创新药物,最初专注于大中华区和其他亚洲市场的授权资产。该公司有目的地设计了他们的组织,通过识别、采购、开发和商业化候选产品以及与世界各地高度创新的生物制药公司合作,成功地执行他们的愿景。该公司正在建立一个国际基础设施,将他们自己定位为首选合作伙伴,并提供一个平台,以提供进入其目标市场的机会。","exchange":"NASDAQ","name":"联拓生物","nameEN":"LianBio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"联拓生物(LIAN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供联拓生物(LIAN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"联拓生物,LIAN,联拓生物股票,联拓生物股票老虎,联拓生物股票老虎国际,联拓生物行情,联拓生物股票行情,联拓生物股价,联拓生物股市,联拓生物股票价格,联拓生物股票交易,联拓生物股票购买,联拓生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"联拓生物(LIAN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供联拓生物(LIAN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}